Highlights
- •Primary care is now overworked and emotionally drained due to the pandemic.
- •Concerns about infecting a family member is associated with emotionally drain.
- •Telephone was the most common consultation type used to provide diabetes care.
- •The COVID-19 pandemic impact on their practice's ability to provide routine diabetes care.
- •Screening for type 2 diabetes was reported to have been impacted on by 70.6% of people.
Abstract
Background
Aim
Methods
Results
Conclusions
Keywords
Novelty statement
1. Introduction
World Health Organization. Coronavirus disease (COVID-19) outbreak situation. Accessed from: https://www.who.int/emergencies/diseases/novel-coronavirus-2019. (Accessed 18 June 2021).
- Seidu S.
- Gillies C.
- Zaccardi F.
- et al.
2. Aim
- Archer S.
- Calanzani N.
- Honey S.
- et al.
3. Methods
3.1 Setting and data sources
3.2 Outcomes of survey
3.3 Statistical analysis
4. Results
4.1 Characteristics of survey respondents and their practice
Characteristic | Number (%) or mean (SD) |
---|---|
Professional role | |
Nurse/nurse practitioner | 582 (59.7) |
Doctor | 321 (32.9) |
Other | 35 (3.6) |
Pharmacist | 27 (2.8) |
Healthcare assistant | 5 (0.5) |
Dietician | 4 (0.4) |
Paramedic | 1 (0.1) |
Special interest in diabetes | |
Yes | 797 (81.7) |
No | 178 (18.3) |
Age | 52 (9) |
Sex | |
Females | 770 (79.0) |
Males | 173 (17.7) |
Prefer not to say | 32 (3.3) |
Ethnicity | |
White | 709 (72.7) |
Asian/British Asian | 128 (13.1) |
Mixed/multiple ethnic groups | 40 (4.1) |
Black/African/Caribbean/Black British | 38 (3.9) |
Prefer not to say | 34 (3.5) |
Other, please describe your ethnicity in your own words | 18 (1.9) |
Arab | 8 (0.8) |
4.2 Impact of COVID-19 on healthcare professionals involved in diabetes care

4.3 Impact of COVID-19 on delivery of diabetes care




4.4 Role of sociodemographic characteristics on outcomes impacted by the pandemic
Characteristics | OR (95 % CI) | p-Value |
---|---|---|
Age (years) | ||
Per 1-year increase | 1.00 (0.98−1.01) | 0.59 |
≤ 50 | ref | |
>50 | 1.19 (0.86−1.67) | 0.30 |
Sex | ||
Female | ref | |
Male | 0.72 (0.44−1.18) | 0.19 |
Professional role | ||
Other | ref | |
Doctor | 2.52 (1.25−5.07) | 0.01 |
Nurse/nurse practitioner | 1.23 (0.63−2.43) | 0.54 |
Ethnicity | ||
Other | ref | |
Asian/British Asian | 0.88 (0.40−1.90) | 0.74 |
Black/African/Caribbean/Black British | 1.60 (0.55−4.64) | 0.39 |
White | 0.96 (0.53−1.74) | 0.90 |
5. Discussion
5.1 Key findings
5.2 Comparisons with previous studies
- Murris F.
- Huchon C.
- Zilberman S.
- et al.
- Archer S.
- Calanzani N.
- Honey S.
- et al.
- Murris F.
- Huchon C.
- Zilberman S.
- et al.
5.3 Potential explanation of findings
5.4 Implications of findings
5.5 Strengths and limitations
6. Conclusions
Data availability
Funding
Conflict of interest
Data sharing
Appendix A. Survey instrument
By completing this questionnaire, you consent to the pseudonymised use of your answers for scientific research. Do you agree? | |
Yes | |
No | |
Section A. Background: about you and your practice. | |
1 | Which role best describes your professional background? |
Doctor | |
Pharmacist | |
Nurse/Nurse practitioner | |
Dietitian | |
Health care assistant | |
Paramedic | |
Other, please specify | |
2 | Do you have a special interest in diabetes? |
Yes | |
No | |
3 | How old were you on your last birthday? |
<leave open ended> | |
Prefer not to say | |
4 | What is your sex? |
Female | |
Male | |
Prefer not to say | |
5 | How would you describe your practice population? |
More affluent | |
Average or mixed | |
More deprived | |
6 | How would you describe your ethnicity? |
White | |
Mixed/Multiple ethnic groups | |
Asian/British Asian | |
Black/African/Caribbean/Black British | |
Arab | |
Other, please describe your ethnicity in your own words | |
Prefer not to say | |
7 | During the course of the pandemic, have you worked in out-of-hours services with face to face service provision? |
Yes | |
No | |
8 | During the course of the pandemic, have you worked in a COVID hot hub or other service providing face to face assessment of people with suspected or confirmed COVID-19 infection? |
Yes | |
No | |
9 | Have you had an illness episode typical of COVID-19 (i.e. Dry cough, high temperature, altered sense of smell or taste)? |
Yes, and I tested positive | |
Yes, but I tested negative | |
Yes, but I was not tested | |
No Prefer not to say | |
10 | If yes and tested positive, have you been hospitalised with COVID-19? |
Yes | |
No | |
Prefer not to say | |
11 | If yes and tested positive, have you had symptoms that have persisted for longer than 12 weeks, since contracting COVID? |
Yes | |
No | |
Prefer not to say | |
12 | Have you had any household members that have tested positive for COVID-19? |
Yes | |
No | |
Prefer not to say | |
13 | Have you had or are you intending to have a COVID-19 vaccine? |
Yes | |
No | |
Undecided | |
Prefer not to say | |
Section B. The following questions relate to your consultations with your patients with diabetes during the COVID-19 pandemic | |
14 | What consultation methods are you, or have you been using, to provide diabetes care during the pandemic? (please tick all that apply) |
Face-to-face consultation | |
Telephone consultation | |
Video-consultation | |
E-consultation (for example, email or via practice website) | |
Other, please specify | |
15 | What impact do you feel the pandemic has had on your practice’s ability to provide routine diabetes care? |
No or minimal impact | |
Moderate impact | |
Significant impact | |
Very significant impact | |
16 | Compared to before the pandemic, have you changed the method you are using to decide who should be recalled for diabetes annual review? |
Yes | |
No | |
17 | Are you prioritising recalls for diabetes review based on clinical risk? |
Yes | |
No | |
18 | If no, which of the following best describes your practice? |
Our practice doesn't need to, we are able to provide full routine diabetes care as usual | |
Our practice would like to, but has no capacity to do so | |
Our practice is not confident, or is unsure how to prioritise based on clinical risk | |
Other, please specify | |
19 | Typically, at the peaks of the pandemic, how quickly can a person with a diabetes related problem get a response from an appropriate healthcare professional in your organisation? |
Within 1 day (less than 24 h) | |
Within 2 days (between 24 and 48 h) | |
Within 3 days (between 48 and 72 h) | |
Within 3−7 days More than 7 days | |
I don’t know | |
20 | Compared to before the pandemic, when faced with a clinical concern in diabetes care, how easy is it for you to access specialist advice? |
Much easier than before the pandemic | |
Somewhat easier than before the pandemic | |
Same as before the pandemic | |
Somewhat more difficult than before the pandemic | |
Much more difficult than before the pandemic | |
21 | With reference to virtual consultations (whether by telephone, video or e-consultation), on average, and compared to before the pandemic, how long do you feel you need for a consultation with a person with diabetes? |
Much shorter than before the pandemic | |
Slightly shorter than before the pandemic | |
About the same as before the pandemic | |
Slightly longer than before the pandemic | |
Much longer than before the pandemic | |
22 | With regards to people who were previously hard to engage, what impact do you feel the broader range of communication methods has had on engagement? |
Strong positive effect | |
Moderate positive effect | |
No effect | |
Moderate negative effect | |
Severe negative effect | |
I do not know | |
23 | Compared to before the pandemic, how often are you encountering mental health concerns in people with diabetes? |
Significantly less than before the pandemic | |
Slightly less than before the pandemic | |
About the same as before the pandemic | |
Slightly more than before the pandemic | |
Significantly more than before the pandemic | |
24 | What impact do you feel the pandemic has had on your practice's ability to provide routine NHS health checks or screening for type 2 diabetes? |
No or minimal impact | |
Moderate impact | |
Significant impact | |
Very significant impact | |
Section C The following questions are related to your experience of work as a healthcare professional during the peaks of the COVID-19 pandemic. | |
25 | How often do you feel overloaded by work? |
Not at all | |
Occasionally | |
Quite often | |
Very often | |
26 | Has your practice been affected by staff absence due to shielding or illness or self-isoltation due to COVID-19? |
Yes | |
No | |
27 | Compared to before the pandemic, how often do you feel emotionally drained at the end of a working day? |
Significantly less than before the pandemic | |
Slightly less than before the pandemic | |
About the same as before the pandemic | |
Slightly more than before the pandemic | |
Significantly more than before the pandemic | |
28 | Do you worry about getting infected with coronavirus? |
Not at all | |
Occasionally | |
Quite often | |
Very often | |
29 | Do you worry about infecting your family with coronavirus? |
Not at all | |
Occasionally | |
Quite often | |
Very often |
References
- Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study.Lancet. 2020; 395: 1054-1062
World Health Organization. Coronavirus disease (COVID-19) outbreak situation. Accessed from: https://www.who.int/emergencies/diseases/novel-coronavirus-2019. (Accessed 18 June 2021).
- Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia.N. Engl. J. Med. 2020; 382: 1199-1207
- Clinical course and mortality risk of severe COVID-19.Lancet. 2020; 395: 1014-1015
- Markers of liver injury and clinical outcomes in COVID-19 patients: a systematic review and meta-analysis.J. Infect. 2021; 82: 159-198https://doi.org/10.1016/j.jinf.2020.05.045
- The impact of obesity on severe disease and mortality in people with SARS-CoV-2: a systematic review and meta-analysis.Endocrinol. Diabetes Metab. Case Rep. 2020; 4e00176https://doi.org/10.1002/edm2.176
- Prevalence of comorbidities and their association with mortality in patients with COVID-19: a Systematic Review and Meta-analysis.Diabetes Obes. Metab. 2020; : 1915-1924https://doi.org/10.1111/dom.14124
- Pandemic threatens primary care for long term conditions.BMJ. 2020; 371: m3793
- The impact of the COVID-19 pandemic on the care and management of patients with acute cardiovascular disease: a systematic review.Eur. Heart J. Qual. Care Clin. Outcomes. 2021; 7: 18-27
- Indirect impact of the COVID-19 pandemic on hospitalisations for cardiometabolic conditions and their management: A systematic review.Prim. Care Diabetes. 2021; 15: 653-681https://doi.org/10.1016/j.pcd.2021.05.011
- Impact of COVID-19 on routine care for chronic diseases: a global survey of views from healthcare professionals.Diabetes Metab. Syndr. 2020; 14: 965-967
- Type 2 diabetes.Lancet. 2017; 389: 2239-2251
- The economic costs of type 2 diabetes: a global systematic review.Pharmacoeconomics. 2015; 33: 811-831
- Delay in treatment intensification increases the risks of cardiovascular events in patients with type 2 diabetes.Cardiovasc. Diabetol. 2015; 14: 100
- Impact of the COVID-19 pandemic on cancer assessment in primary care: a qualitative study of GP views.BJGP Open. 2021; 5https://doi.org/10.3399/BJGPO.2021.0056
- The Impact of COVID-19 on Primary Care General Practice Consultations in a Teaching Hospital in Shanghai, China.Front. Med. (Lausanne). 2021; 8642496
- Impact of the COVID-19 pandemic on the core functions of primary care: will the cure be worse than the disease? A qualitative interview study in Flemish GPs.BMJ Open. 2020; 10e039674
- Survey of AAHKS international members on the impact of COVID-19 on hip and knee arthroplasty practices.J. Arthroplasty. 2020; 35: S89-S94
- Impact of the first lockdown for Coronavirus 19 on Breast Cancer management in France: a Multicentre survey.J. Gynecol. Obstet. Hum. Reprod. 2021; 50102166https://doi.org/10.1016/j.jogoh.2021.102166
- Older adults report cancellation or avoidance of medical care during the COVID-19 pandemic: results from the Longitudinal Aging Study Amsterdam.Eur. Geriatr. Med. 2021; 12: 1075-1083https://doi.org/10.1007/s41999-021-00514-3
- Indirect acute effects of the COVID-19 pandemic on physical and mental health in the UK: a population-based study.Lancet Digit Health. 2021; 3: e217-e230
- Novel influenza A(H1N1) in a pediatric health care facility in New York City during the first wave of the 2009 pandemic.Arch. Pediatr. Adolesc. Med. 2010; 164: 24-30
- A rapid medical screening process improves emergency department patient flow during surge associated with novel H1N1 influenza virus.Ann. Emerg. Med. 2011; 57: 52-59
- Impact of severe acute respiratory syndrome (SARS) outbreaks on the use of emergency department medical resources.J. Chin. Med. Assoc. 2005; 68: 254-259
- Impact of the 2015 middle east respiratory syndrome outbreak on emergency care utilization and mortality in South Korea.Yonsei Med. J. 2019; 60: 796-803
- Rada AG. Covid-19: how doctors and healthcare systems are tackling coronavirus worldwide.BMJ. 2020; 368: m1090
- Screening for kidney disease in adults with diabetes.Diabetes Care. 2005; 28: 1813-1816
- Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes.N. Engl. J. Med. 2003; 348: 383-393